In this episode of the EuCornea IME video interview series on ocular surface disease (OSD), Profs. Mario Nubile and Sotiria Palioura discuss why OSD screening is essential before cataract and refractive surgery. Despite its high prevalence, meibomian gland dysfunction (MGD) often goes undetected, leading to suboptimal outcomes and patient dissatisfaction. The experts share practical strategies for systematic OSD evaluation, MGD management, and patient education to enhance surgical precision, safety, and patient satisfaction.